BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1287028)

  • 1. Serum drug level monitoring in affective disorders.
    Krska J; Corner DA
    J Clin Pharm Ther; 1992 Dec; 17(6):357-63. PubMed ID: 1287028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The lithium concentration of the blood plasma in combined therapy with lithium carbonate and carbamazepine].
    Skorik AI
    Farmakol Toksikol; 1991; 54(4):57-9. PubMed ID: 1786831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
    Lenzi A; Lazzerini F; Placidi GF; Cassano GB; Akiskal HS
    Pharmacopsychiatry; 1989 Jan; 22(1):34-7. PubMed ID: 2652160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination.
    Kishimoto A
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):483-93. PubMed ID: 1641493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders.
    Nolen WA; Jansen GS; Broekman M
    Pharmacopsychiatry; 1988 Sep; 21(5):252-4. PubMed ID: 3227056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the psychotropic action of lithium and carbamazepine.
    Rybakowski J
    Pharmacol Toxicol; 1992; 71 Suppl 1():30-41. PubMed ID: 1480559
    [No Abstract]   [Full Text] [Related]  

  • 8. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
    Fawcett J; Kravitz HM
    J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.
    Marcus SC; Olfson M; Pincus HA; Zarin DA; Kupfer DJ
    Am J Psychiatry; 1999 Jul; 156(7):1014-8. PubMed ID: 10401444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study.
    Sashidharan SP; McGuire RJ; Glen AI
    Br J Psychiatry; 1982 Jun; 140():619-22. PubMed ID: 7104552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva for monitoring of patients with primary affective disorders.
    Ben-Aryeh H; Laor R; Szargel R; Gutman D; Naon H; Pascal M; Hefetz A
    Isr J Med Sci; 1984 Mar; 20(3):197-201. PubMed ID: 6427134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment.
    George MS; Rosenstein D; Rubinow DR; Kling MA; Post RM
    Psychiatry Res; 1994 Feb; 51(2):139-46. PubMed ID: 8022948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of a single-point dosing protocol for predicting steady-state lithium levels.
    Perry PJ; Alexander B; Prince RA; Dunner FJ
    Br J Psychiatry; 1986 Apr; 148():401-5. PubMed ID: 3089352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of carbamazepine-induced hyponatremia among patients also given lithium.
    Vieweg V; Glick JL; Herring S; Kerler R; Godleski LS; Barber J; Yank G; Spradlin W
    Am J Psychiatry; 1987 Jul; 144(7):943-7. PubMed ID: 3605408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correct treatment of mood disorders with lithium].
    Haussmann R; Lewitzka U; Severus E; Bauer M
    Nervenarzt; 2017 Nov; 88(11):1323-1334. PubMed ID: 28980047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity.
    Wijeratne C; Draper B
    Aust N Z J Psychiatry; 2011 Dec; 45(12):1026-32. PubMed ID: 21961481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydipsia, hyponatremia, and psychosis.
    Vieweg WV; Godleski LS
    Am J Psychiatry; 1989 Jan; 146(1):124. PubMed ID: 2912236
    [No Abstract]   [Full Text] [Related]  

  • 19. Asterixis induced by psychotropic drug treatment.
    Rittmannsberger H
    Clin Neuropharmacol; 1996 Aug; 19(4):349-55. PubMed ID: 8828998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia associated with carbamazepine: case report and review.
    Baciewicz G; Yerevanian BI
    J Clin Psychiatry; 1984 Jul; 45(7):315-6. PubMed ID: 6735991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.